Abstract:Irritable bowel syndrome (IBS) is characterized by abdominal discomfort and irregular bowel movements and stool consistency. As such, the gut microbiome has been posited as being influential for the syndrome. However, identifying microbial features associated with IBS symptom heterogeneity is difficult without large cohorts. Our aim was to identify microbial features associated with IBS and IBS subtypes compared to healthy controls and to determine if a synbiotic supplementation intervention could decrease the proportion of those microbial features. Stool samples from 490 individuals with IBS (including all dominant subtypes) and 122 individuals without IBS were analyzed with metagenomic sequencing. One hundred thirty-four IBS subjects were followed over time while receiving daily synbiotic supplementation, the composition of which varied between participants. IBS participants had significantly lower alpha diversity, an enrichment in Gram-negative bacteria, and a reduction in pathways associated with short-chain fatty acid and vitamin synthesis. Shigella species were significantly associated with IBS, while Eubacterium rectale and Faecalibacterium prausnitzii were associated with healthy controls. Random forest identified unique and overlapping microbial features associated with each IBS subtype. Longitudinal assessment of 134 IBS subjects receiving synbiotic supplements demonstrated a significant difference in microbial features and an increase in probiotic abundance across time. We identified microbial features that differentiate healthy and IBS subtypes. Synbiotic supplementation in IBS subjects did not result in alpha diversity change in the microbiome but did demonstrate changes in microbial features. Future work is needed to determine if the observed microbiome changes are associated with IBS symptom improvement. IMPORTANCE An estimated 35 million people in the United States and 11.5% of the population globally are affected by IBS. Immunity, genetics, environment, diet, small intestinal bacterial overgrowth (SIBO), and the gut microbiome are all factors that contribute to the onset or triggers of IBS. With strong supporting evidence that the gut microbiome may influence symptoms associated with IBS, elucidating the important microbes that contribute to the symptoms and severity is important to make decisions for targeted treatment. As probiotics have become more common in treating IBS symptoms, identifying effective probiotics may help inform future studies and treatment.

Gut Microbiota and Irritable Bowel Syndrome: Status and Prospect

Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome

Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome

Gut microbiota and intestinal immunity—A crosstalk in irritable bowel syndrome

Analysis of the status of intestinal microecology and irritable bowel syndrome

The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy

Research progress of the relationship of gut microbiota, gut-brain axis with irritable bowel syndrome

Intestinal Microecology and Quality of Life in Irritable Bowel Syndrome Patients

The Relationship Between Gut Microbiota and Proteolytic Activity in Irritable Bowel Syndrome.

Microbiome and Its Role in Irritable Bowel Syndrome

Cross-Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment

Microbiome Shifts and Their Impact on Gut Physiology in Irritable Bowel Syndrome

Intestinal Crosstalk between Bile Acids and Microbiota in irritable bowel syndrome

Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation

Advances in Study on Intestinal Flora Disorder and Irritable Bowel Syndrome

IDENTIFICATION OF GUT MICROBIOTA AND METABOLITES SIGNATURE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME

The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome

Integrated Multi-Omics Data Analysis Reveals Altered Metabolome Activity and Microbiome Composition in Irritable Bowel Syndrome

Alterations of Gut Microbiota in Patients with Irritable Bowel Syndrome Based on 16S Rrna-Targeted Sequencing: A Systematic Review

Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review